AIDS Dementia Complex
Research from Food & Drug Administration in the area of AIDS dementia complex published
Published in Medical Letter on the CDC and FDA, June 6th, 2010
"We report the results of the up-to-60-week open-label phase following the double-blind phase. Participants received open-label memantine and were escalated to a 40 mg/day dose or their maximum tolerated dose in the double-blind phase. Adverse experiences were used to evaluate safety, and changes in the mean of eight...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- HIV/AIDS
Data on HIV/AIDS detailed by A.A. Date and co-authors - Public Health
National Center for Injury Prevention and Control publishes research in public health - Intercellular Signaling Peptides and Proteins
New intercellular signaling peptides and proteins research reported from J.A. Belser and co-authors - Neurocysticercosis
Reports on neurocysticercosis findings from S. Handali and co-researchers provide new insights - Curettage
Study results from National Center for Chronic Disease Prevention and Health Promotion in the area of curettage published - Diabetes
Research from Food & Drug Administration provides new data on diabetes - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
